ZW14792A1 - "Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-/-d-fructopyranose and (1-methylcyclohexyl) methanol" - Google Patents

"Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-/-d-fructopyranose and (1-methylcyclohexyl) methanol"

Info

Publication number
ZW14792A1
ZW14792A1 ZW14792A ZW14792A ZW14792A1 ZW 14792 A1 ZW14792 A1 ZW 14792A1 ZW 14792 A ZW14792 A ZW 14792A ZW 14792 A ZW14792 A ZW 14792A ZW 14792 A1 ZW14792 A1 ZW 14792A1
Authority
ZW
Zimbabwe
Prior art keywords
chlorosulfate
fructopyranose
methylethylidene
methylcyclohexyl
bis
Prior art date
Application number
ZW14792A
Other languages
English (en)
Inventor
Cynthia Maryanoff
Lorraine Scott
Kirk Sorgi
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of ZW14792A1 publication Critical patent/ZW14792A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/34—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfuric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D309/06—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZW14792A 1991-09-19 1992-09-18 "Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-/-d-fructopyranose and (1-methylcyclohexyl) methanol" ZW14792A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76272091A 1991-09-19 1991-09-19
US92626992A 1992-08-05 1992-08-05

Publications (1)

Publication Number Publication Date
ZW14792A1 true ZW14792A1 (en) 1994-04-20

Family

ID=27117178

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW14792A ZW14792A1 (en) 1991-09-19 1992-09-18 "Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-/-d-fructopyranose and (1-methylcyclohexyl) methanol"

Country Status (23)

Country Link
US (1) US5387700A (xx)
EP (1) EP0533483B1 (xx)
JP (1) JP3174410B2 (xx)
KR (1) KR100229180B1 (xx)
CN (1) CN1035820C (xx)
AT (1) ATE163937T1 (xx)
AU (1) AU651244B2 (xx)
CA (1) CA2078519C (xx)
DE (1) DE69224691T2 (xx)
DK (1) DK0533483T3 (xx)
EG (1) EG20164A (xx)
ES (1) ES2114917T3 (xx)
FI (1) FI107731B (xx)
GR (1) GR3026618T3 (xx)
HU (1) HU212634B (xx)
IL (1) IL103172A (xx)
MX (1) MX9205305A (xx)
MY (1) MY113564A (xx)
NO (1) NO179284C (xx)
NZ (1) NZ244409A (xx)
PH (1) PH31291A (xx)
TW (1) TW217413B (xx)
ZW (1) ZW14792A1 (xx)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3250777B2 (ja) * 1995-02-13 2002-01-28 セントラル硝子株式会社 イミド類、その塩類およびそれらの製造法
UA65607C2 (uk) * 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування
NZ513724A (en) * 1999-02-17 2004-01-30 Ortho Mcneil Pharm Inc Anticonvulsant derivatives useful in treating essential tremor
US6420369B1 (en) 1999-05-24 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating dementia
DE60118206T2 (de) * 2000-07-07 2006-12-14 Ortho-Mcneil Pharmaceutical, Inc. Antikonvulsive derivate zur behandlung und vorbeugung der entwicklung von typ ii diabetes und syndrom x
AU2001280865A1 (en) 2000-08-02 2002-02-13 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful for the treatment of depression
WO2002064210A2 (en) * 2000-10-30 2002-08-22 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising anti-diabetic and anticonvulsant agents
US7041650B2 (en) * 2001-07-09 2006-05-09 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivative salts
UA78211C2 (en) * 2001-07-09 2007-03-15 Ortho Mcneil Pharm Inc Salts of fructopyranose derivatives as anticonvulsant
MXPA04004380A (es) * 2001-11-06 2005-06-08 Johnson & Johnson Tratamiento y prevencion de parestesia que comprende co-terapia con derivados anticonvulsivos y potasio.
RU2004126093A (ru) * 2002-02-26 2005-04-10 Орто-Макнейл Фармасьютикал, Инк. (Us) Комбинированная терапия для лечения мигрени, включающая применение производных противосудорожных средств и средств от мигрени
EP1494998A2 (en) 2002-03-01 2005-01-12 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US7060725B2 (en) * 2002-05-13 2006-06-13 Janssen Pharmaceutica N.V. Substituted sulfamate anticonvulsant derivatives
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
EP1534238A1 (en) * 2002-07-29 2005-06-01 ALZA Corporation Formulations and dosage forms for controlled delivery of topiramate
UA80450C2 (en) * 2002-10-31 2007-09-25 Ortho Mcneil Pharm Inc Continuous process for the preparation of fructopyranose sulfamate derivatives
US7196209B2 (en) * 2002-10-31 2007-03-27 Ortho-Mcneil Pharmaceutical, Inc. Continuous process for the preparation of fructopyranose sulfamate derivatives
UA81657C2 (ru) * 2003-03-04 2008-01-25 Орто-Макнейл Фармасьютикел, Инк. Способ получения противосудорожных производных топирамата
WO2004108732A1 (en) * 2003-05-12 2004-12-16 Sun Pharmaceutical Industries Limited PROCESS FOR THE PREPARATION OF 2,3:4,5-BIS-O(1-METHYLETHYLIDENE)-ß-D-FRUCTOPYRANOSE SULFAMATE
CA2534920A1 (en) * 2003-08-06 2005-02-24 Alza Corporation Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
US20050136108A1 (en) * 2003-08-22 2005-06-23 Yam Noymi V. Stepwise delivery of topiramate over prolonged period of time
WO2005020959A2 (en) * 2003-09-02 2005-03-10 Alza Corporation Novel drug compositions and dosage forms of topiramate
JP2007511519A (ja) * 2003-11-14 2007-05-10 アルザ・コーポレーシヨン 液状投薬形態物におけるトピラメートの制御放出
KR20050062976A (ko) * 2003-12-19 2005-06-28 일동제약주식회사 2,3:4,5-비스-오-(1-메틸에틸리덴)-베타-디-프럭토피라노즈설파메이트의 새로운 개량된 제조방법
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
EP1701708A2 (en) * 2003-12-29 2006-09-20 Alza Corporation Novel drug compositions and dosage forms of topiramate
JP2007517061A (ja) * 2003-12-29 2007-06-28 アルザ・コーポレーシヨン 新規薬剤組成物及び投与形態物
US20050203287A1 (en) * 2004-03-11 2005-09-15 Chandrasekhar Batchu Process for the preparation of sulfamate derivatives
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AR049646A1 (es) * 2004-06-16 2006-08-23 Janssen Pharmaceutica Nv Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
MY142329A (en) * 2004-08-24 2010-11-15 Janssen Pharmaceutica Nv Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents.
DK1815165T3 (da) * 2004-10-05 2012-06-18 Fallbrook Technologies Inc Trinløst variabel transmission
AU2006249577A1 (en) * 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
AU2006251213A1 (en) * 2005-05-25 2006-11-30 Janssen Pharmaceutica N.V. Pediatric formulation of topiramate
US8937096B2 (en) * 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8492431B2 (en) * 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
US8497298B2 (en) * 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US20070191461A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
US20070191474A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
US20070191453A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction
US20070191449A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
US20070191459A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels
WO2007099388A1 (en) * 2006-03-01 2007-09-07 Glade Organics Private Limited An improved process for the manufacture of topiramate
WO2007108009A1 (en) * 2006-03-17 2007-09-27 Alembic Limited A process for purification of topiramate
JP2009537635A (ja) * 2006-05-19 2009-10-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 癲癇の処置のための共同−療法
JP5424571B2 (ja) * 2007-04-12 2014-02-26 協和発酵キリン株式会社 トピラマート含有固形製剤
JP5591686B2 (ja) * 2007-04-24 2014-09-17 フォールブルック インテレクチュアル プロパティー カンパニー エルエルシー 電気牽引駆動装置
CN101450951B (zh) * 2007-11-30 2012-10-10 重庆凯林制药有限公司 托吡酯的制备方法
US20090247616A1 (en) * 2008-03-26 2009-10-01 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
US20090247617A1 (en) * 2008-03-26 2009-10-01 Abdel-Magid Ahmed F Process for the preparation of benzo-fused heteroaryl sulfamates
CA2729056A1 (en) 2008-06-23 2010-01-21 Janssen Pharmaceutica Nv Crystalline form of (2s)-(-)-n-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) * 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
WO2011096934A1 (en) 2010-02-05 2011-08-11 Scinopharm Taiwan, Ltd. Process for the preparation and purification of topiramate
CN102936268A (zh) * 2012-11-13 2013-02-20 江苏吉贝尔药业有限公司 一种托吡酯中间体丙酮叉的制备方法
CN106397502A (zh) * 2016-08-31 2017-02-15 安徽省润生医药股份有限公司 一种托吡酯的合成工艺
CN108341844A (zh) * 2018-04-25 2018-07-31 广州小桔生物科技有限公司 一种高纯度托吡酯的制备方法
CN110655541A (zh) * 2018-06-29 2020-01-07 鲁南制药集团股份有限公司 一种2,3:4,5-双-O-(1-甲基亚乙基)-β-D-吡喃果糖氯磺酸酯晶型
CN110655542A (zh) * 2018-06-29 2020-01-07 鲁南制药集团股份有限公司 一种2,3:4,5-双-O-(1-甲基亚乙基)-β-D-吡喃果糖氯磺酸酯的晶型
EP3883546A1 (en) 2018-11-21 2021-09-29 Rosemont Pharmaceuticals Ltd Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
CN114350340B (zh) * 2022-01-13 2023-01-17 陕西科技大学 一种压裂用增渗剂及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582916A (en) * 1983-09-26 1986-04-15 Mcneilab, Inc. Chlorosulfate and azidosulfate esters of tetrahydro-2H-pyran-2-yl-methanol
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives

Also Published As

Publication number Publication date
EP0533483A3 (en) 1994-11-02
AU2451892A (en) 1993-03-25
MY113564A (en) 2002-04-30
TW217413B (xx) 1993-12-11
KR100229180B1 (ko) 1999-11-01
DK0533483T3 (da) 1998-09-28
US5387700A (en) 1995-02-07
NO179284C (no) 1996-09-11
EP0533483B1 (en) 1998-03-11
CA2078519C (en) 2003-09-16
MX9205305A (es) 1993-07-01
EG20164A (en) 1997-08-31
IL103172A (en) 1997-01-10
NZ244409A (en) 1995-02-24
FI924189A0 (fi) 1992-09-18
KR930006029A (ko) 1993-04-20
NO179284B (no) 1996-06-03
DE69224691T2 (de) 1998-08-20
CN1035820C (zh) 1997-09-10
JP3174410B2 (ja) 2001-06-11
DE69224691D1 (de) 1998-04-16
EP0533483A2 (en) 1993-03-24
NO923637L (no) 1993-03-22
PH31291A (en) 1998-07-06
GR3026618T3 (en) 1998-07-31
AU651244B2 (en) 1994-07-14
HU9202974D0 (en) 1992-11-30
HUT63612A (en) 1993-09-28
HU212634B (en) 1996-09-30
JPH05230011A (ja) 1993-09-07
IL103172A0 (en) 1993-02-21
ES2114917T3 (es) 1998-06-16
ATE163937T1 (de) 1998-03-15
FI924189A (fi) 1993-03-20
CN1075317A (zh) 1993-08-18
FI107731B (fi) 2001-09-28
CA2078519A1 (en) 1993-03-20
NO923637D0 (no) 1992-09-18

Similar Documents

Publication Publication Date Title
ZW14792A1 (en) "Process for the preparation of chlorosulfate and sulfamate derivatives of 2,3:4,5-bis-0-(1-methylethylidene)-/-d-fructopyranose and (1-methylcyclohexyl) methanol"
CA2157800A1 (en) Tamper respondent enclosure
MX9101524A (es) Proceso para la sintesis de un copolimero de isopreno-butadieno con alto contenido de vinilo
ATE211724T1 (de) Verfahren zur herstellung von 4-hydroxystyrol
HUT64604A (en) Method for producing endo-bicyclo(2,2,1)-heptane-2-ol derivatives and enzymatical separating the substance obtaine therefrom
BR9607149A (pt) Produção e recuperação de éter dimetílico a partir de metanol
EP0616994A3 (en) Process for the preparation of ether alcohols by hydrogenolysis of cyclic ketals.
EP0380750A3 (en) Glycidyl azide polymer and method of preparation
CA2055483A1 (en) Polyester chain-extended vinyl ether urethane oligomers
FR2661872B1 (fr) Procede de fabrication d'un pare-soleil recouvert de tissu.
AU9002291A (en) A process for producing alkoxysilane-terminated polyethers
EP0476528A3 (en) Process for producing stable latex
AU598565B2 (en) Process for producing alpha-l-aspartyl-l-phenylalanine methyl ester having an improved solubility
HU904906D0 (en) Process for producing alpha-1-aspartil-1-phenylalanine-methyl-esther-hydrochloride utilizing separated n-formyl-1-aspartil-anhydride
AU590439B2 (en) Process for producing alpha-L-aspartyl-L-phenylalanine methyl ester having an improved solubility
IT7829321A0 (it) Processo pert la preparazione di un copolimero di esteri vinilici.
ATE165328T1 (de) Verfahren zur herstellung von halogenierten alkoholen
AU8404291A (en) Device for producing hollow glass mouldings
EP0454494A3 (en) Calicheamicinone, derivatives and analogs thereof and methods of making the same
EP0637776A4 (en) PHOTOSENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING A RELIEF CONFIGURATION FROM THIS COMPOSITION.
AU628251B2 (en) Method for culturing a chlorella
HUT60324A (en) Process for producing compositions of yeast biomass base
AU7971891A (en) Process for producing enantiomer-pure alpha-hydroxylproponioaldehyde derivatives
AU8121591A (en) Novel process for producing 6-acyl-7-deacetylforskolin derivatives